Increased platelet reactivity in dyslipidemic patients with coronary artery disease on dual anti-platelet therapy

INTRODUCTION: The optimal duration of dual anti-platelet therapy (DAPT) following percutaneous coronary intervention (PCI) is still a matter of debate. Biomarkers may help to identify patients who will benefit from extended DAPT. The aim of the study was to test the interaction between lipid paramet...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Arch Med Sci
Main Authors: Jäger, Bernhard, Piackova, Editha, Haller, Paul Michael, Andric, Tijana, Kahl, Beatrice, Christ, Günther, Geppert, Alexander, Wojta, Johann, Huber, Kurt
Format: Artigo
Jezik:Inglês
Izdano: Termedia Publishing House 2018
Teme:
Clinical Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6348363/
https://ncbi.nlm.nih.gov/pubmed/30697254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2018.81035
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki